Company: CDT
Filing Date: 2025-02-11
Form Type: 8-K
Source: 0001493152-25-005796
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-02-11
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01. Other Events

In
an effort to reduce its outstanding debt, on February 7, 2025, Conduit Pharmaceuticals Inc. (the
“

In
addition, as of February 10, 2025, with respect to the Lender’s Senior Note, as defined below, pursuant
to the terms of the Senior Note, the Lender has previously converted approximately $1.7 million of the original principal amount of $2,650,000
under the Senior Note into shares of common stock of the Company. As previously disclosed, on August 6, 2024, as subsequently amended
in October and November of 2024, the Company had entered into a Senior Secured Promissory Note (the “ Senior Note”) and a
security agreement with the Lender, pursuant to which the Company issued and sold the Senior Note in the original principal amount of
$2,650,000, inclusive of a $500,000 original issuance discount. The Senior Note bears interest at a rate of 12% per annum, accruing daily
on a 365-day basis, payable monthly in arrears as cash, or accrued at the Lender’s discretion.

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

                CONDUIT                                      
  February      By:                       /s/                
                Name:                     David              
                Title:                    Chief